These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16646057)

  • 21. LupusQoL, a new systemic lupus erythematosus-specific quality of life measure: comment on the article by McElhone et al.
    Leong KP; Kong KO; Howe HS
    Arthritis Rheum; 2008 Jul; 59(7):1047-8; author reply 1048-9. PubMed ID: 18576300
    [No Abstract]   [Full Text] [Related]  

  • 22. Epigenetic considerations in investigating the cause of systemic lupus erythematosus: comment on the article by Chagnon et al.
    Brooks WH
    Arthritis Rheum; 2007 Mar; 56(3):1035. PubMed ID: 17330258
    [No Abstract]   [Full Text] [Related]  

  • 23. Epitope spreading in systemic lupus erythematosus: comment on the article by Monneaux and Muller.
    Hoffman RW; Greidinger EL
    Arthritis Rheum; 2003 Feb; 48(2):582-3. PubMed ID: 12571876
    [No Abstract]   [Full Text] [Related]  

  • 24. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
    Wenzel J; Zahn S; Bieber T; Tüting T
    Arch Dermatol Res; 2009 Jan; 301(1):83-6. PubMed ID: 18784932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus.
    Cuchacovich R; Gedalia A
    Rheum Dis Clin North Am; 2009 Feb; 35(1):75-93. PubMed ID: 19480998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosteroids in preventing severe lupus flares: do all patients have the same risk? Comment on the article by Tseng et al.
    Callejas-Rubio JL; Rios-Fernández R; Tomás-Jiménez C; Ortego-Centeno N
    Arthritis Rheum; 2007 Jun; 56(6):2098-9; author reply 2099. PubMed ID: 17530655
    [No Abstract]   [Full Text] [Related]  

  • 27. Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: comment on the article by Compeyrot-Lacassagne et al.
    Praprotnik S; Tomsic M
    Arthritis Rheum; 2007 Dec; 56(12):4228; author reply 4228-9. PubMed ID: 18050257
    [No Abstract]   [Full Text] [Related]  

  • 28. Contraception in adolescents with systemic lupus erythematosus.
    Tincani A; Nuzzo M; Lojacono A; Cattalini M; Meini A
    Lupus; 2007; 16(8):600-5. PubMed ID: 17711895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional components to measuring fatigue in patients with systemic lupus erythematosus: comment on the article by the Ad Hoc Committee on systemic lupus erythematosus response criteria for fatigue.
    Wallace DJ
    Arthritis Rheum; 2008 Jul; 59(7):1049; author reply 1049-50. PubMed ID: 18576308
    [No Abstract]   [Full Text] [Related]  

  • 30. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema.
    Khan S; Tarzi MD; Doré PC; Sewell WA; Longhurst HJ
    Clin Immunol; 2007 Apr; 123(1):14-7. PubMed ID: 17098477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus and "lupus dyslipoproteinemia".
    de Carvalho JF; Bonfá E; Borba EF
    Autoimmun Rev; 2008 Jan; 7(3):246-50. PubMed ID: 18190886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients.
    Praprotnik S; Sodin-Semrl S; Tomsic M; Shoenfeld Y
    J Autoimmun; 2008; 30(1-2):37-41. PubMed ID: 18158235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of sensitive assays to detect soluble Fas in patients with systemic lupus erythematosus: comment on the article by Knipping et al and the article by Goel et al.
    Mountz JD; Zhou T; Cheng J
    Arthritis Rheum; 1996 Sep; 39(9):1611-2. PubMed ID: 8814076
    [No Abstract]   [Full Text] [Related]  

  • 35. [Systemic lupus erythematosus--a contemporary view of its genetic determination, immunopathogenesis and therapy].
    Buc M; Rovenský J
    Epidemiol Mikrobiol Imunol; 2009 Feb; 58(1):3-14. PubMed ID: 19358447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases.
    Cavagna L; Caporali R; Esposito C; Augetti C; Epis O; Montecucco C
    Scand J Rheumatol; 2007; 36(1):74-6. PubMed ID: 17454941
    [No Abstract]   [Full Text] [Related]  

  • 37. Careful attention to blood sampling as a preanalytical determinant of circulating matrix metalloproteinase 9 to avoid misinterpretations: comment on the article by Ainiala et al.
    Jung K
    Arthritis Rheum; 2005 Feb; 52(2):673-4; author reply 674. PubMed ID: 15692966
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients: comment on the article by Valero-Gonzalez et al.
    Balta I; Balta S; Ozturk C; Kurtoglu E
    Scand J Rheumatol; 2014; 43(5):432. PubMed ID: 24749842
    [No Abstract]   [Full Text] [Related]  

  • 39. Survival Analysis Is Preferable to a Count of Events When Assessing the Effects of Tobacco Exposure in Systemic Lupus Erythematosus: Comment on the Article by Montes et al.
    Reygaerts T; Arnaud L; Devilliers H
    Arthritis Rheumatol; 2016 Apr; 68(4):1046-7. PubMed ID: 26713539
    [No Abstract]   [Full Text] [Related]  

  • 40. Late onset systemic lupus erythematosus: a new approach.
    Karoubi Nordon E; Hayem G; Mentres F; Palazzo E; Legrain S; Meyer O; Raveau P
    Lupus; 2007; 16(12):1011-4. PubMed ID: 18042600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.